As of January 22, 2025, Phathom Pharmaceuticals (PHAT) has a market cap of $0.48 billion USD. According to our data, Phathom Pharmaceuticals is ranked No.6176 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.48 B |
-13.92%
|
Dec 31, 2024 | $0.56 B |
-11.06%
|
Dec 29, 2023 | $0.62 B |
-18.63%
|
Dec 30, 2022 | $0.77 B |
-42.96%
|
Dec 31, 2021 | $1.34 B |
-40.79%
|
Dec 31, 2020 | $2.27 B |
6.68%
|
Dec 31, 2019 | $2.13 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Ironwood Pharmaceuticals
IRWD
|
$0.60 B |
0.000 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Takeda Pharmaceutical
TAK
|
$40.87 B |
0.001 M
|
Japan
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Market Cap | = | PHAT Stock Price | * | PHAT Shares Outstanding |
= | $6.99 | * | 68.38 M | |
= | $0.48 B |